tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Dermatitis D003872 30 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Pharyngitis D010612 2 associated lipids
Shock D012769 11 associated lipids
Erythema D004890 22 associated lipids
Dermatomycoses D003881 17 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Amenorrhea D000568 4 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Shock, Septic D012772 11 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Cough D003371 19 associated lipids
Paraproteinemias D010265 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Ovarian Cysts D010048 4 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Renal D006977 9 associated lipids
Metaplasia D008679 7 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Tachycardia D013610 7 associated lipids
Cicatrix D002921 9 associated lipids
Neutropenia D009503 15 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Urticaria D014581 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Thrombophlebitis D013924 6 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Kim SK et al. Inflammatory mimetic microfluidic chip by immobilization of cell adhesion molecules for T cell adhesion. 2012 Analyst pmid:22822477
Park JY et al. Monitoring the status of T-cell activation in a microfluidic system. 2011 Analyst pmid:21623432
Brecht S et al. FK506 protects against various immune responses and secondary degeneration following cerebral ischemia. 2009 Anat Rec (Hoboken) pmid:19728359
Georgiou GK et al. Calcineurin inhibitors and male fertility after renal transplantation - a review. 2016 Andrologia pmid:26341518
Lang-Lazdunski L et al. The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats. 2001 Anesth. Analg. pmid:11323353
Siniscalchi A et al. Opioid-induced hyperalgesia and rapid opioid detoxification after tacrolimus administration. 2008 Anesth. Analg. pmid:18227327
Brooksbank RL et al. Treatment of normal skeletal muscle with FK506 or rapamycin results in halothane-induced muscle contracture. 1998 Anesthesiology pmid:9743407
Chini EN and Walker H FK506 (tacrolimus) increases halothane-induced Ca2+ release from skeletal muscle sarcoplasmic reticulum. 2000 Anesthesiology pmid:10781282
Brittain DE et al. Total synthesis of antascomicin B. 2005 Angew. Chem. Int. Ed. Engl. pmid:15806607
Lee KB et al. Direct monitoring of the inhibition of protein-protein interactions in cells by translocation of PKCδ fusion proteins. 2011 Angew. Chem. Int. Ed. Engl. pmid:21290501
McKenzie KM et al. Simultaneous identification of multiple protein targets by using complementary-DNA phage display and a natural-product-mimetic probe. 2004 Angew. Chem. Int. Ed. Engl. pmid:15300693
Feng S et al. A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. 2014 Angew. Chem. Int. Ed. Engl. pmid:24841150
Althoff EA and Cornish VW A bacterial small-molecule three-hybrid system. 2002 Angew. Chem. Int. Ed. Engl. pmid:12203581
Elisaf M and Mikhailidis DP Statins and renal function. 2002 Sep-Oct Angiology pmid:12365855
Wüthrich B et al. Atopic eczema: genetics or environment? 2007 Ann Agric Environ Med pmid:18247450
Sahu MK et al. High blood tacrolimus and hyperkalemia in a heart transplant patient. Ann Card Anaesth pmid:28393798
Philippe F et al. [Drug eluting stents: from evidence based medicine to clinical practice]. 2005 Ann Cardiol Angeiol (Paris) pmid:16104621
Panis Y and Valleur P [Small intestine transplantation. Experimental and clinical results]. 1993 Ann Chir pmid:7504899
Busque S et al. [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus]. 1999 Ann Chir pmid:10584376
Martin D et al. [First case in the world of autoreplantation of a limb associated with oral administration of an immunosupressant agent (FK 506-Tacrolimus)]. 2005 Ann Chir Plast Esthet pmid:16087038
Moncourier M et al. [Granulomatous periocular eruption]. Ann Dermatol Venereol pmid:28410769
Mirkamali A et al. [Ulcerated necrobiosis lipoidica: successful treatment with topical tacrolimus and hydroxychloroquine]. 2010 Aug-Sep Ann Dermatol Venereol pmid:20804904
Parodi A et al. Treatment of rosacea. 2011 Ann Dermatol Venereol pmid:22183101
Schmutz JL et al. [Pimecrolimus and vaccinations]. 2007 Jun-Jul Ann Dermatol Venereol pmid:17702119
Alquier-Bouffard A et al. [Chronic actinic dermatitis: treatment with topical tacrolimus (two cases)]. 2007 Jun-Jul Ann Dermatol Venereol pmid:17657183
Schmutz JL [No increased risk of cancer under pimecrolimus]. 2016 Ann Dermatol Venereol pmid:26708204
Parodi A et al. [Treatment of rosacea]. 2011 Ann Dermatol Venereol pmid:21907876
Mahé E et al. [Plane warts in areas of atopic dermatitis treated with tacrolimus ointment]. 2006 Aug-Sep Ann Dermatol Venereol pmid:17053745
Girault PY et al. [Topical tacrolimus in chronic actinic dermatitis]. 2008 Ann Dermatol Venereol pmid:18929923
Rouxel AM et al. [Tacrolimus mouthwash as second-line treatment for erosive oral lichen planus]. 2010 Ann Dermatol Venereol pmid:20932447
Schmutz JL et al. [Contact allergy with tacrolimus then pimecrolimus]. 2008 Ann Dermatol Venereol pmid:18342086
Skowron F et al. [Important systemic absorption of topical tacrolimus during treatment of severe pemphigus vulgaris]. 2005 Ann Dermatol Venereol pmid:15924053
Martel J et al. [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. 2001 Ann Dermatol Venereol pmid:11275588
Nouchi A et al. [Treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) using topical tacrolimus: Two cases]. 2015 Ann Dermatol Venereol pmid:25778634
Reynaert G et al. [Streptococcal impetigo at topical tacrolimus application sites in a woman with atopic dermatitis]. 2007 Ann Dermatol Venereol pmid:17389853
Paul C [Science, marketing and pharmacovigilance: the example of topical calcineurin inhibitors]. 2007 Ann Dermatol Venereol pmid:18033059
Al Gain M et al. [Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus]. 2015 Ann Dermatol Venereol pmid:25683011
Chiheb S et al. [Behçet's disease]. 2003 Jun-Jul Ann Dermatol Venereol pmid:13679709
Baubion E et al. [Oral lichen planus and treatment with topical tacrolimus rinse]. 2009 Ann Dermatol Venereol pmid:19328313
Henno A et al. [Improvement of Netherton syndrome associated erythroderma in two adult sisters through use of topical pimecrolimus]. 2006 Ann Dermatol Venereol pmid:16495860
Michel JL and Gain P [Topical tacrolimus treatment for ocular cicatricial pemphigoid]. 2006 Ann Dermatol Venereol pmid:16508602
Lacour JP [Topical tacrolimus in dermatology: what can one expect?]. 2001 Ann Dermatol Venereol pmid:11908129
Macario-Barrel A et al. [Mouth ulcers in patients receiving tacrolimus]. 2001 Ann Dermatol Venereol pmid:11908135
Firmin D et al. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease]. 2008 Ann Dermatol Venereol pmid:18374862
Ferraro V et al. [Efficacy of topical tacrolimus in Hailey-Hailey disease]. 2006 Ann Dermatol Venereol pmid:16760841
Fery-Blanco C et al. [Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: efficacy of cidofovir]. 2007 Ann Dermatol Venereol pmid:17507844
Lübbe J and Saurat JH [A monograph on topical tacrolimus (Protopic]. 2003 Ann Dermatol Venereol pmid:12700537
de Prost Y [The value of topical immunosuppressors in the treatment of atopic dermatitis in children]. 2005 Ann Dermatol Venereol pmid:15984296
Nicolie B [What is the treatment for atopic dermatitis flares in children?]. 2005 Ann Dermatol Venereol pmid:15984308
de Prost Y [Can the precautionary principle obstruct therapeutic progress?]. 2005 Aug-Sep Ann Dermatol Venereol pmid:16230911